S. Walsh

Publications178
h-index43
Citations6,630
Highly Influential Citations237
Claim Author Page
Author pages are created from data sourced from our academic publisher partnerships and public sources.

Recommended Authors

  • G. Bigelow
  • 380 Publications • 16,784 Citations
  • M. Lofwall
  • 103 Publications • 2,168 Citations
  • K. Preston
  • 276 Publications • 11,116 Citations
  • E. Strain
  • 222 Publications • 8,430 Citations
  • Publications
  • Influence
Clinical pharmacology of buprenorphine: Ceiling effects at high doses
The purpose of this study was to characterize the acute effects of buprenorphine, an opioid partial (μ‐agonist, across a wide range of doses in comparison to methadone.
  • 626
  • 21
Methadone safety: a clinical practice guideline from the American Pain Society and College on Problems of Drug Dependence, in collaboration with the Heart Rhythm Society.
UNLABELLED Methadone is used for the treatment of opioid addiction and for treatment of chronic pain. The safety of methadone has been called into question by data indicating a large increase in the… Expand
  • 153
  • 13
  • PDF
Oral Cannabidiol does not Alter the Subjective, Reinforcing or Cardiovascular Effects of Smoked Cannabis
Cannabidiol (CBD), a constituent of cannabis with few psychoactive effects, has been reported in some studies to attenuate certain aspects of Δ9-tetrahydrocannabinol (THC) intoxication. However, most… Expand
  • 99
  • 13
  • PDF
Acute administration of buprenorphine in humans: partial agonist and blockade effects.
Buprenorphine, a mixed opioid agonist-antagonist, is being investigated as a treatment for opioid dependence. This study compared the acute subjective and physiological effects of sublingual… Expand
  • 269
  • 11
The relative abuse liability of oral oxycodone, hydrocodone and hydromorphone assessed in prescription opioid abusers.
Abuse of prescription opioids has risen precipitously in the United States. Few controlled comparisons of the abuse liability of the most commonly abused opioids have been conducted. This outpatient… Expand
  • 126
  • 9
A comparison of levomethadyl acetate, buprenorphine, and methadone for opioid dependence.
BACKGROUND Opioid dependence is a chronic, relapsing disorder with important public health implications. METHODS In a 17-week randomized study of 220 patients, we compared levomethadyl acetate (75… Expand
  • 408
  • 8
Enadoline, a selective kappa opioid agonist: comparison with butorphanol and hydromorphone in humans
Abstract. Rationale: The availability of the highly selective and specific kappa opioid agonist enadoline provides an opportunity to explore the function of kappa receptors in humans and their… Expand
  • 198
  • 7
A Review of Buprenorphine Diversion and Misuse: The Current Evidence Base and Experiences From Around the World
Outpatient opioid addiction treatment with sublingual buprenorphine pharmacotherapy has rapidly expanded in the United States and abroad, and, with this increase in medication availability, there… Expand
  • 133
  • 7
Gabapentin misuse, abuse and diversion: a systematic review.
BACKGROUND AND AIMS Since its market release, gabapentin has been presumed to have no abuse potential and subsequently has been prescribed widely off-label, despite increasing reports of gabapentin… Expand
  • 144
  • 7
  • PDF
Enadoline and butorphanol: evaluation of kappa-agonists on cocaine pharmacodynamics and cocaine self-administration in humans.
Preclinical studies have demonstrated that kappa-opioid agonists can attenuate the neurochemical and behavioral effects of cocaine that are related to its reinforcing efficacy, suggesting that… Expand
  • 104
  • 7
  • PDF
...
1
2
3
4
5
...